Rhythm Pharmaceuticals Inc (RYTM)
$92.57 -0.54% Close Oct 30, 2026 Live
Rhythm Pharmaceuticals stock today
Rhythm Pharmaceuticals closed at $92.57 on October 30, 2026, down 0.54% on the day. Over the past year it returned -17.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $6.34 billion.
$80.00$100.00
NovJan 2026MarMayJulSep
| Period | RYTM | S&P 500 (SPY) |
|---|---|---|
| 1 month | -2.8% | -0.9% |
| 3 months | -12.5% | +2.1% |
| Year to date | -13.5% | +11.7% |
| 1 year | -17.2% | +12.4% |
| 3 years | +306.5% | +88.5% |
| 5 years | +704.3% | +76.0% |
Key statistics
- Market value
- $6.34B
- Price / sales
- 26.4
- 52-week range
- $75.82 to $117.62
- Next report
- Nov 3, 2026
About Rhythm Pharmaceuticals
Rhythm Pharmaceuticals develops and commercializes treatments for rare genetic disorders of obesity.
Sector: Health Care
More on Rhythm Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +46% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $8,043 today
No forecast, no recommendation. This page describes Rhythm Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.